Clinical Trial Update: Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in Senegal [NA]

View source ↗

Summary

A completed study in Senegal compared misoprostol delivered via Uniject to oxytocin for the prevention of postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Misoprostol (Cytotec) (misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED